Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.
Calanzani N, Druce PE, Snudden C, Milley KM, Boscott R, Behiyat D, Saji S, Martinez-Gutierrez J, Oberoi J, Funston G, Messenger M, Emery J, Walter FM. Calanzani N, et al. Among authors: oberoi j. Adv Ther. 2021 Feb;38(2):793-834. doi: 10.1007/s12325-020-01571-z. Epub 2020 Dec 11. Adv Ther. 2021. PMID: 33306189 Free PMC article. Review.
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, Bickerstaffe A, Dowty JG, De Abreu Lourenço R, Clark M, Galloway L, Fishman G, Walter FM, Flander L, Chondros P, Ait Ouakrim D, Pirotta M, Trevena L, Jenkins MA, Emery JD. Walker JG, et al. Among authors: oberoi j. Trials. 2018 Jul 25;19(1):397. doi: 10.1186/s13063-018-2764-7. Trials. 2018. PMID: 30045764 Free PMC article.
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.
Druce P, Calanzani N, Snudden C, Milley K, Boscott R, Behiyat D, Martinez-Gutierrez J, Saji S, Oberoi J, Funston G, Messenger M, Walter FM, Emery J. Druce P, et al. Among authors: oberoi j. Adv Ther. 2021 Jun;38(6):3032-3065. doi: 10.1007/s12325-021-01645-6. Epub 2021 Apr 27. Adv Ther. 2021. PMID: 33907946 Free PMC article.
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
Emery JD, Jenkins MA, Saya S, Chondros P, Oberoi J, Milton S, Novy K, Habgood E, Karnchanachari N, Pirotta M, Trevena L, Bickerstaffe A, De Abreu Lourenço R, Crothers A, Ouakrim DA, Flander L, Dowty JG, Walter FM, Clark M, Doncovio S, Etemadmoghadam D, Fishman G, Macrae F, Winship I, McIntosh JG. Emery JD, et al. Among authors: oberoi j. Br J Gen Pract. 2023 Jul 27;73(733):e556-e565. doi: 10.3399/BJGP.2022.0480. Print 2023 Aug. Br J Gen Pract. 2023. PMID: 37012077 Free PMC article. Clinical Trial.
Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer.
Ahanin EF, Sager RA, Backe SJ, Dunn DM, Dushukyan N, Blanden AR, Mate NA, Suzuki T, Anderson T, Roy M, Oberoi J, Prodromou C, Nsouli I, Daneshvar M, Bratslavsky G, Woodford MR, Bourboulia D, Chisholm JD, Mollapour M. Ahanin EF, et al. Among authors: oberoi j. Cell Chem Biol. 2023 Oct 19;30(10):1223-1234.e12. doi: 10.1016/j.chembiol.2023.06.026. Epub 2023 Jul 31. Cell Chem Biol. 2023. PMID: 37527661
Invasive fungal infections in hemato-oncology.
Oberoi JK, Sheoran L, Sagar T, Saxena S. Oberoi JK, et al. Indian J Med Microbiol. 2023 Jul-Aug;44:100353. doi: 10.1016/j.ijmmb.2023.01.011. Epub 2023 May 12. Indian J Med Microbiol. 2023. PMID: 37356843 Review.
68 results